Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1066790

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1066790

Asia Breast Cancer Screening Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis

PUBLISHED:
PAGES: 240 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Excel (Dashboard)
USD 1990
PDF (Single User License)
USD 2490
PDF (5 User License + Excel)
USD 2990
PDF (Corporate License)
USD 3490

Add to Cart

Asia Breast Cancer Screening Market is expected to reach USD 16.5 Billion by 2027. Breast cancer is a disease in which cells in breast tissue change and divide uncontrolled, typically resulting in a lump or mass. Remarkably, Asia is the world's largest continent comprising millions of the human population. Breast cancer is the most familiar type of cancer and the second leading cause of cancer-related deaths among women in Asia. Besides, the incidence of breast cancer in Asia varies widely across the continent, and cancer rates are increasing rapidly in parallel to socio-economic development.

Asia Breast Cancer Screening Industry is expected to expand at a CAGR of 8.5% during 2021-2027:

The major driving forces for expanding the breast cancer screening market in Asia are increasing breast cancer awareness, government and NGOs supporting breast cancer screening programs, and the aging population.

Nevertheless, critical threats for the breast cancer screening market in Asia are societal fear, misconceptions, and cultural barriers. Another major challenge being faced by almost all Asian countries is the non-availability of national-level screening programs; however, partial or regional screening programs are available in a few of Asian countries.

Mammogram Screening Leads Breast Cancer Screening in Asia:

Our report studies Breast Cancer Screening in Asia through Mammography Screening, MRI Screening, and Ultrasound Screening. As per our analysis, the mammogram is the leading method for breast cancer screening in Asian countries. Further, we have also made the market estimation that China, Japan, and Korea are the top three countries for breast cancer mammogram screening. Other Asian countries included in our study are India, Singapore, Malaysia, and Thailand for breast cancer mammogram screening.

China Holds Significant Dominance in Asia Breast Cancer Screening Market:

Our report studies the breast cancer screening market of Asian countries like India, China, Japan, Korea, Singapore, Thailand, and Malaysia. As per our analysis, China, Japan, and Korea are the top-most contributors to the breast cancer screening industry. In addition, China holds significant dominance in the Asia breast cancer screening market. Further, a prominent women population and domestic NGOs initiatives support China to become a leader in the Asian breast cancer screening market.

COVID-19 Impact on the Asia Breast Cancer Screening Industry:

Globally, over a billion people had been affected due to novel Coronavirus for the first time in 2020. The whole world had been facing problems in healthcare and the financial world during the pandemic era. Besides, most healthcare centers had reserved their team and resources for the treatment of COVID-19 patients, and due to this outbreak, women avoided diagnostics centers as lockdowns were imposed by governments across the world, declining the market. As per Renub Research report, Asia Breast Cancer Screening Market Size was USD 10.1 Billion in 2021 post recovery from the pandemic.

Key Players:

The companies contributing to the growth of the Asia breast cancer screening market include: AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, GlaxoSmithKline plc, Hoffmann-La Roche Ltd., and Sun Pharmaceutical Industries Ltd. The market players are considerably contributing to market growth by adopting various strategies, including new product launches, mergers and acquisitions, collaborations with the government, and technological advancements to stay competitive in the market.

Renub Research study titled "Asia Breast Cancer Screening Market Forecast By Population Analysis (Mammography, MRI & Ultrasound),Market Analysis (Mammography Screening Market, MRI Screening Market, Ultrasound Screening Market), Countries (India, China, Japan, Korea, Singapore, Thailand and Malaysia), Company (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, GlaxoSmithKline plc, Hoffmann-La Roche Ltd., and Sun Pharmaceutical Industries Ltd.)" provides a detailed analysis of Asia Breast Cancer Screening Industry.

Asia Breast Cancer Screening Population Analysis has been covered from 2 viewpoints:

  • 1. Mammography Screening Population
  • 2. MRI & Ultrasound Screening Population

Asia Breast Cancer Screening Market Analysis has been covered from 3 viewpoints:

  • 1. Mammography Screening Market
  • 2. MRI Screening Market
  • 3. Ultrasound Screening Market

Countries covered in Asia Breast Cancer Screening Market Analysis have been covered from 7 viewpoints:

  • 1. India
  • 2. China
  • 3. Japan
  • 4. Korea
  • 5. Singapore
  • 6. Thailand
  • 7. Malaysia

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Company Analysis:

  • 1. AstraZeneca
  • 2. Novartis
  • 3. Sanofi
  • 4. Pfizer
  • 5. Bayer AG
  • 6. GlaxoSmithKline plc
  • 7. Hoffmann-La Roche Ltd.
  • 8. Sun Pharmaceutical Industries Ltd

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Asia Breast Cancer Screening Population Analysis

  • 5.1 Mammography Screening Population
  • 5.2 MRI & Ultrasound Screening Population

6. Asia Breast Cancer Screening Market Analysis

  • 6.1 Breast Cancer Screening Market
    • 6.1.1 Mammography Screening Market
    • 6.1.2 MRI Screening Market
    • 6.1.3 Ultrasound Screening Market

7. Population Share - Asia Breast Cancer Screening

  • 7.1 Mammography Screening Population Share
  • 7.2 MRI & Ultrasound Screening Population Share

8. Market Share - Asia Breast Cancer Screening Analysis

  • 8.1 Asia Breast Cancer Screening Market Share
  • 8.2 Mammography Screening Market Share
  • 8.3 MRI Screening Market Share
  • 8.4 Ultrasound Screening Market Share

9. India

  • 9.1 India Breast Cancer Mammography Screening Population
  • 9.2 India Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 9.3 India Breast Cancer Screening Market
    • 9.3.1 Mammography Screening Market
    • 9.3.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 9.3.3 Ultrasound Screening Market

10. China

  • 10.1 China Breast Cancer Mammography Screening Population
  • 10.2 China Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 10.3 China Breast Cancer Screening Market & Forecast
    • 10.3.1 Mammography Screening Market
    • 10.3.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 10.3.3 Ultrasound Screening Market

11. Japan

  • 11.1 Japan Breast Cancer Mammography Screening Population
  • 11.2 Japan Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 11.3 Japan Breast Cancer Screening Market
    • 11.3.1 Mammography Screening Market
    • 11.3.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 11.3.3 Ultrasound Screening Market

12. Korea

  • 12.1 Korea Breast Cancer Mammography Screening Population
  • 12.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 12.3 Korea Breast Cancer Screening Market
    • 12.3.1 Mammography Screening Market
    • 12.3.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 12.3.3 Ultrasound Screening Market

13. Singapore

  • 13.1 Singapore Breast Cancer Mammography Screening Population
  • 13.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 13.3 Singapore Breast Cancer Screening Market
    • 13.3.1 Mammography Screening Market
    • 13.3.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 13.3.3 Ultrasound Screening Market

14. Thailand

  • 14.1 Thailand Breast Cancer Mammography Screening Population
  • 14.2 Thailand Breast Czancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 14.3 Thailand Breast Cancer Screening Market
    • 14.3.1 Mammography Screening Market
    • 14.3.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 14.3.3 Ultrasound Screening Market

15. Malaysia

  • 15.1 Malaysia Breast Cancer Mammography Screening Population
  • 15.2 Malaysia Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 15.3 Malaysia Breast Cancer Screening Market
    • 15.3.1 Mammography Screening Market
    • 15.3.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 15.3.3 Malaysia Breast Cancer Ultrasound Screening Market

16. Porters Five Forces

  • 16.1 Overview
  • 16.2 Bargaining Power of Buyers
  • 16.3 Bargaining Power of Suppliers
  • 16.4 Degree of Competition
  • 16.5 Threat of New Entrants
  • 16.6 Threat of Substitutes

17. Company Analysis

  • 17.1 AstraZeneca
    • 17.1.1 Overview
    • 17.1.2 Recent Development
    • 17.1.3 Revenue
  • 17.2 Novartis
    • 17.2.1 Overview
    • 17.2.2 Recent Development
    • 17.2.3 Revenue
  • 17.3 Sanofi
    • 17.3.1 Overview
    • 17.3.2 Recent Development
    • 17.3.3 Revenue
  • 17.4 Pfizer
    • 17.4.1 Overview
    • 17.4.2 Recent Development
    • 17.4.3 Revenue
  • 17.5 Bayer AG
    • 17.5.1 Overview
    • 17.5.2 Recent Development
    • 17.5.3 Revenue
  • 17.6 GlaxoSmithKline plc
    • 17.6.1 Overview
    • 17.6.2 Recent Development
    • 17.6.3 Revenue
  • 17.7 Hoffmann-La Roche Ltd.
    • 17.7.1 Overview
    • 17.7.2 Recent Development
    • 17.7.3 Revenue
  • 17.8 Sun Pharmaceutical Industries Ltd
    • 17.8.1 Overview
    • 17.8.2 Recent Development
    • 17.8.3 Revenue

List of Figures

  • Figure-01: Asia - Breast Cancer Mammography Screening Population (Million), 2016 - 2021
  • Figure-02: Asia - Forecast for Breast Cancer Mammography Screening Population (Million), 2022 - 2027
  • Figure-03: Asia - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-04: Asia - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-05: Asia - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-06: Asia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-07: Asia - Breast Cancer MRI Screening Market (Million US$), 2016 - 2021
  • Figure-08: Asia - Forecast for Breast Cancer MRI Screening Market (Million US$), 2022 - 2027
  • Figure-09: Asia - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-10: Asia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-11: India - Breast Cancer Mammography Screening Population (Thousand), 2016 - 2021
  • Figure-12: India - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 - 2027
  • Figure-13: India - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-14: India - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-15: India - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-16: India - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-17: India - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 - 2021
  • Figure-18: India - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 - 2027
  • Figure-19: India - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-20: India - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-21: China - Breast Cancer Mammography Screening Population (Thousand), 2016 - 2021
  • Figure-22: China - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 - 2027
  • Figure-23: China - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-24: China - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-25: China - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-26: China - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-27: China - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 - 2021
  • Figure-28: China - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 - 2027
  • Figure-29: China - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-30: China - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-31: Japan - Breast Cancer Mammography Screening Population (Thousand), 2016 - 2021
  • Figure-32: Japan - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 - 2027
  • Figure-33: Japan - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-34: Japan - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-35: Japan - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-36: Japan - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-37: Japan - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 - 2021
  • Figure-38: Japan - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 - 2027
  • Figure-39: Japan - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-40: Japan - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-41: Korea - Breast Cancer Mammography Screening Population (Thousand), 2016 - 2021
  • Figure-42: Korea - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 - 2027
  • Figure-43: Korea - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-44: Korea - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-45: Korea - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-46: Korea - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-47: Korea - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 - 2021
  • Figure-48: Korea - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 - 2027
  • Figure-49: Korea - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-50: Korea - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-51: Singapore - Breast Cancer Mammography Screening Population (Thousand), 2016 - 2021
  • Figure-52: Singapore - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 - 2027
  • Figure-53: Singapore - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-54: Singapore - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-55: Singapore - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-56: Singapore - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-57: Singapore - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 - 2021
  • Figure-58: Singapore - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 - 2027
  • Figure-59: Singapore - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-60: Singapore - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-61: Thailand - Breast Cancer Mammography Screening Population (Thousand), 2016 - 2021
  • Figure-62: Thailand - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 - 2027
  • Figure-63: Thailand - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-64: Thailand - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-65: Thailand - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-66: Thailand - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-67: Thailand - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 - 2021
  • Figure-68: Thailand - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 - 2027
  • Figure-69: Thailand - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-70: Thailand - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-71: Malaysia - Breast Cancer Mammography Screening Population (Thousand), 2016 - 2021
  • Figure-72: Malaysia - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 - 2027
  • Figure-73: Malaysia - Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 - 2021
  • Figure-74: Malaysia - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 - 2027
  • Figure-75: Malaysia - Breast Cancer Mammography Screening Market (Million US$), 2016 - 2021
  • Figure-76: Malaysia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 - 2027
  • Figure-77: Malaysia - Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 - 2021
  • Figure-78: Malaysia - Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 - 2027
  • Figure-79: Malaysia - Breast Cancer Ultrasound Screening Market (Million US$), 2016 - 2021
  • Figure-80: Malaysia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 - 2027
  • Figure-81: AstraZeneca - Global Revenue (Million US$), 2016 - 2021
  • Figure-82: AstraZeneca - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-83: Novartis - Global Revenue (Million US$), 2016 - 2021
  • Figure-84: Novartis - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-85: Sanofi - Global Revenue (Million US$), 2016 - 2021
  • Figure-86: Sanofi - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-87: Pfizer - Global Revenue (Million US$), 2016 - 2021
  • Figure-88: Pfizer - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-89: Bayer AG - Global Revenue (Million US$), 2016 - 2021
  • Figure-90: Bayer AG - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-91: GlaxoSmithKline plc - Global Revenue (Million US$), 2016 - 2021
  • Figure-92: GlaxoSmithKline plc - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-93: Hoffmann-La Roche Ltd. - Global Revenue (Million US$), 2016 - 2021
  • Figure-94: Hoffmann-La Roche Ltd. - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-95: Sun Pharmaceutical Industries Ltd - Global Revenue (Million US$), 2016 - 2021
  • Figure-96: Sun Pharmaceutical Industries Ltd - Forecast for Global Revenue (Million US$), 2022 - 2027

List of Tables

  • Table-01: Asia - Mammography Screening Population Share by Country (Percent), 2016 - 2021
  • Table-02: Asia - Forecast for Mammography Screening Population Share by Country (Percent), 2022 - 2027
  • Table-03: Asia - MRI & Ultrasound Screening Population Share by Country (Percent), 2016 - 2021
  • Table-04: Asia - Forecast for MRI & Ultrasound Screening Population Share by Country (Percent), 2022 - 2027
  • Table-05: Asia - Breast Cancer Screening Market Share by Country (Percent), 2016 - 2021
  • Table-06: Asia - Forecast for Breast Cancer Screening Market Share by Country (Percent), 2022 - 2027
  • Table-07: Asia - Mammography Screening Market Share by Country (Percent), 2016 - 2021
  • Table-08: Asia - Forecast for Mammography Screening Market Share by Country (Percent), 2022 - 2027
  • Table-09: Asia - MRI Screening Market Share by Country (Percent), 2016 - 2021
  • Table-10: Asia - Forecast for MRI Screening Market Share by Country (Percent), 2022 - 2027
  • Table-11: Asia - Ultrasound Screening Market Share by Country (Percent), 2016 - 2021
  • Table-12: Asia - Forecast for Ultrasound Screening Market Share by Country (Percent), 2022 - 2027
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!